NCT02736968: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02736968 |
|---|---|
| Title | Phase IIa Randomized, Single-Blinded, Placebo-Controlled Clinical Trial of the Reprofiled Drug Auranofin for GI Protozoa |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Nov. 6, 2016 |
| Completion date | March 10, 2021 |
| Required reporting date | March 10, 2024, midnight |
| Actual reporting date | Nov. 17, 2022 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |